Director, Portfolio and Decision Analysis
Joel is a Director in Pfizer’s Portfolio and Decision Analysis group, focused on ensuring robust R&D portfolio investment decisions in the late-stage clinical portfolio. Prior joining the Portfolio and Decision Analysis group in 2017, he spent 2 years in Pfizer’s internal consulting group working on efforts to boost R&D productivity. He received a Ph.D. in Pharmacology from Cornell in 2014, with a thesis on the pharmacological characterization of the Sigma1 Receptor and relevant therapeutic applications. He also completed his MBA at Cornell in 2015.
Outside of work, Joel is an avid ultramarathoner and, before becoming a father, a bass guitar player in several cover bands. He now spends most of his free time chasing his toddler, but still finds time for his hobbies, including researching how companies outside the pharmaceutical industry use data to make decisions. He enjoys working with graduate students to help them prepare for the pharmaceutical industry, and is passionate about making connections between academia and business.